Abstract:Background Quantitative susceptibility mapping (QSM) is a quantitative measure based on magnetic resonance imaging sensitive to iron and myelin content. This makes QSM a promising non-invasive tool for multiple sclerosis (MS) in research and clinical practice. Objective We performed a systematic review and meta-analysis on the use of QSM in MS. Methods Our review was prospectively registered on PROSPERO (CRD42022309563). We searched five databases for studies published between inception and 30th April 2023. We identified 83 English peer-reviewed studies that applied QSM images on MS cohorts. Fifty-five included studies had at least one of the following outcome measures: deep grey matter QSM values in MS, either compared to healthy controls (HC) (k = 13) or correlated with the score on the Expanded Disability Status Scale (EDSS) (k = 7), QSM lesion characteristics (k = 22) and their clinical correlates (k = 17), longitudinal correlates (k = 11), histological correlates (k = 7), or correlates with other imaging techniques (k = 12). Two meta-analyses on deep grey matter (DGM) susceptibility data were performed, while the remaining findings could only be analyzed descriptively. Results After outlier removal, meta-analyses demonstrated a significant increase in the basal ganglia susceptibility (QSM values) in MS compared to HC, caudate (k = 9, standardized mean difference (SDM) = 0.54, 95 % CI = 0.39–0.70, I 2 = 46 %), putamen (k = 9, SDM = 0.38, 95 % CI = 0.19–0.57, I 2 = 59 %), and globus pallidus (k = 9, SDM = 0.48, 95 % CI = 0.28–0.67, I 2 = 60 %), whereas thalamic QSM values exhibited a significant reduction (k = 12, SDM = −0.39, 95 % CI = −0.66–−0.12, I 2 = 84 %); these susceptibility differences in MS were independent of age. Further, putamen QSM values positively correlated with EDSS (k = 4, r = 0.36, 95 % CI = 0.16–0.53, I 2 = 0 %). Regarding rim lesions, four out of seven studies, representing 73 % of all patients, reported rim lesions to be associated with more severe disability. Moreover, lesion development from initial detection to the inactive stage is paralleled by increasing, plateauing (after about two years), and gradually decreasing QSM values, respectively. Only one longitudinal study provided clinical outcome measures and found no association. Histological data suggest iron content to be the primary source of QSM values in DGM and at the edges of rim lesions; further, when also considering data from myelin water imaging, the decrease of myelin is likely to drive the increase of QSM values within WM lesions Conclusions We could provide meta-analytic evidence for DGM susceptibility changes in MS compared to HC; basal ganglia susceptibility is increased and, in the putamen, associated with disability, while thalamic susceptibility is decreased. Beyond these findings, further investigations are necessary to establish the role of QSM in MS for research or even clinical routine.

MEDI+0: Morphology Enabled Dipole Inversion with Automatic Uniform Cerebrospinal Fluid Zero Reference for Quantitative Susceptibility Mapping

Clinical Feasibility of Brain Quantitative Susceptibility Mapping.

Cerebral Microbleeds: Burden Assessment by Using Quantitative Susceptibility Mapping

Clinical Quantitative Susceptibility Mapping (QSM): Biometal Imaging and Its Emerging Roles in Patient Care

Abstract WP292: Quantitative Susceptibility Mapping for Reliably Measuring Hematoma Volume in Magnetic Resonance Imaging

Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping.

MoG-QSM: Model-based Generative Adversarial Deep Learning Network for Quantitative Susceptibility Mapping.

MoDL-QSM: Model-based Deep Learning for Quantitative Susceptibility Mapping

Quantitative Susceptibility Mapping As a Biomarker for Evaluating White Matter Alterations in Parkinson's Disease.

Deep grey matter quantitative susceptibility mapping from small spatial coverages using deep learning

A method for estimating and removing streaking artifacts in quantitative susceptibility mapping

CSF Susceptibility Variation in Patient With Intracranial Hemorrhage: Implications for Quantitative Susceptibility Mapping Reference Selection

Single‐step Calculation of Susceptibility Through Multiple Orientation Sampling

Quantitative susceptibility mapping using multi-channel convolutional neural networks with dipole-adaptive multi-frequency inputs

MR Susceptibility Separation for Quantifying Lesion Paramagnetic and Diamagnetic Evolution in Relapsing–Remitting Multiple Sclerosis

Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis

Multi-Echo Quantitative Susceptibility Mapping for Strategically Acquired Gradient Echo (STAGE) Imaging

MRI Tissue Magnetism Quantification through Total Field Inversion with Deep Neural Networks

Deep Quantitative Susceptibility Mapping for Background Field Removal and Total Field Inversion

Quantitative Susceptibility Mapping Using Structural Feature Based Collaborative Reconstruction (sfcr) in the Human Brain

[Research Progress of Quantitative Susceptibility Mapping in MRI].